Search for other papers by Ruth Percik in
Google Scholar
PubMed
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Search for other papers by Kate Young in
Google Scholar
PubMed
Royal Marsden Hospital, London, UK
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
of the grade. Furthermore, some endocrine irAEs require adjustment and correlation with standard endocrine diagnostic criteria (e.g. hyperglycaemia). These recommendations complement published guidance, including emergency management guidelines
Search for other papers by Yiqiong Ma in
Google Scholar
PubMed
Search for other papers by Zhaowei Chen in
Google Scholar
PubMed
Search for other papers by Yu Tao in
Google Scholar
PubMed
Search for other papers by Jili Zhu in
Google Scholar
PubMed
Search for other papers by Hongxia Yang in
Google Scholar
PubMed
Search for other papers by Wei Liang in
Google Scholar
PubMed
Search for other papers by Guohua Ding in
Google Scholar
PubMed
). Furthermore, mitochondria are considered dynamic organelles that periodically divide (fission) and fuse (fusion) ( 11 ). These dynamic processes maintain stable mitochondrial mass and quantity ( 12 ). It was reported that hyperglycaemia results in increased
Search for other papers by Bliss Anderson in
Google Scholar
PubMed
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
) Usually 1–3 months after treatment Hyperglycaemia and new-onset diabetes Approximately 1% (59) Anti-PD-1/PD-L1 (58, 61, 62) Polydipsia, polyuria, weight loss Hyperglycaemia on fasting and random glucose samples, HbA1c Persistent
Search for other papers by Rama Lakshman in
Google Scholar
PubMed
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK
Search for other papers by Charlotte Boughton in
Google Scholar
PubMed
Search for other papers by Roman Hovorka in
Google Scholar
PubMed
Introduction Over nine million people worldwide live with type 1 diabetes (T1D) ( 1 ). In this condition, immune-mediated destruction of pancreatic beta-cells leads to insulin deficiency and resultant hyperglycaemia. The management of T1D
Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed
Search for other papers by Othmar Moser in
Google Scholar
PubMed
Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed
Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed
Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed
Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed
Search for other papers by Harald Sourij in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Faculty of Medicine, University of Latvia, Riga, Latvia
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
process primes the body for food intake and glucose replenishment ( Fig. 1A ). Following a meal, hyperglycaemia triggers the secretion of GLP-1 and insulin. GLP-1 reduces gastric emptying and appetite. Both GLP-1 and insulin suppress glucagon secretion
Search for other papers by Chenghao Piao in
Google Scholar
PubMed
Search for other papers by Xiaojie Wang in
Google Scholar
PubMed
Search for other papers by Shiqiao Peng in
Google Scholar
PubMed
Search for other papers by Xinyu Guo in
Google Scholar
PubMed
Search for other papers by Hui Zhao in
Google Scholar
PubMed
Search for other papers by Li He in
Google Scholar
PubMed
Search for other papers by Yan Zeng in
Google Scholar
PubMed
Search for other papers by Fan Zhang in
Google Scholar
PubMed
Search for other papers by Kewen Zhu in
Google Scholar
PubMed
Search for other papers by Yiwei Wang in
Google Scholar
PubMed
vital biomarker of intrauterine hyperglycaemia and a predictor of insulin dysfunction in the foetus of patients with GDM. Bush et al . discovered that maternal hyperglycaemia is positively associated with insulin resistance and pancreatic β cell
Search for other papers by Paraskevi Kazakou in
Google Scholar
PubMed
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Theodora Psaltopoulou in
Google Scholar
PubMed
Search for other papers by Maria Gavriatopoulou in
Google Scholar
PubMed
Search for other papers by Eleni Korompoki in
Google Scholar
PubMed
Search for other papers by Katerina Stefanaki in
Google Scholar
PubMed
Search for other papers by Fotini Kanouta in
Google Scholar
PubMed
Search for other papers by Georgia N Kassi in
Google Scholar
PubMed
Search for other papers by Meletios-Athanasios Dimopoulos in
Google Scholar
PubMed
Search for other papers by Asimina Mitrakou in
Google Scholar
PubMed
diabetic people with obesity may negatively affect the immune response ( 19 , 20 , 21 ). Growing data indicate also that hyperglycaemia on admission and during hospitalization in people with or without diabetes is a predictor of worse prognosis, severity
Search for other papers by E N Dudinskaya in
Google Scholar
PubMed
Search for other papers by O N Tkacheva in
Google Scholar
PubMed
Search for other papers by M V Shestakova in
Google Scholar
PubMed
Search for other papers by N V Brailova in
Google Scholar
PubMed
Search for other papers by I D Strazhesko in
Google Scholar
PubMed
Search for other papers by D U Akasheva in
Google Scholar
PubMed
Search for other papers by O Y Isaykina in
Google Scholar
PubMed
Search for other papers by N V Sharashkina in
Google Scholar
PubMed
Search for other papers by D A Kashtanova in
Google Scholar
PubMed
Search for other papers by S A Boytsov in
Google Scholar
PubMed
(3) . Experimental data show that glucose metabolism disorders induce vascular changes. For instance, Facchini et al . (4) showed that hyperinsulinaemia regardless of hyperglycaemia may promote oxidative stress and thereby accelerate vascular
Search for other papers by Janaína Felix Braga in
Google Scholar
PubMed
Search for other papers by Daniela Ravizzoni Dartora in
Google Scholar
PubMed
Search for other papers by Natalia Alenina in
Google Scholar
PubMed
Search for other papers by Michael Bader in
Google Scholar
PubMed
Cardiology Institute of Rio Grande do Sul/University Foundation of Cardiology (IC/FUC), Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Robson Augusto Souza Santos in
Google Scholar
PubMed
patients with diabetes improves glucose tolerance ( 30 , 31 ). These observations support a role for glucagon, and probably Mas, in diabetes hyperglycaemia. Conclusion The main finding of this report is the marked increase in the number and per
Faculty of Medicine, University of Oslo, Oslo, Norway
Search for other papers by Espen Nordheim in
Google Scholar
PubMed
Search for other papers by Jørn Petter Lindahl in
Google Scholar
PubMed
Search for other papers by Rasmus Kirkeskov Carlsen in
Google Scholar
PubMed
Department of Pharmacy, University of Oslo, Oslo, Norway
Search for other papers by Anders Åsberg in
Google Scholar
PubMed
Faculty of Medicine, University of Oslo, Oslo, Norway
Search for other papers by Kåre Inge Birkeland in
Google Scholar
PubMed
Search for other papers by Rune Horneland in
Google Scholar
PubMed
Department of Behavioural Medicine, University of Oslo, Oslo, Norway
Search for other papers by Birgitte Boye in
Google Scholar
PubMed
Centre of Excellence-HTH, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Search for other papers by Hanne Scholz in
Google Scholar
PubMed
Faculty of Medicine, University of Oslo, Oslo, Norway
Metabolic and Renal Research Group, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway
Search for other papers by Trond Geir Jenssen in
Google Scholar
PubMed
1 diabetes. Patients with different phenotypes of diabetes have been accepted, the major categories being patients with persistent hyperglycaemia (HbA1c > 10% (>86 mmol/mol)), patients with recurring episodes of hypoglycaemia or with fluctuating or